Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Titan Pharma (TTNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Biotech Stocks Beating the Market

HENDERSON, NV / ACCESSWIRE / December 10, 2018 / Here are several biotech plays to pay close attention to in the coming sessions.

CRON : 11.28 (-0.88%)
TTNP : 0.27 (unch)
CLVS : 20.76 (-4.02%)
MNKD : 1.68 (-1.75%)
Alternatives to Watch

HENDERSON, NV / ACCESSWIRE / December 10, 2018 / Below are several companies positioning themselves to be a viable opioid alternative.

CARA : 14.05 (-0.21%)
COLL : 18.14 (-3.05%)
TTNP : 0.27 (unch)
INSY : 4.91 (-0.41%)
ENDV : 0.0224 (-8.57%)
Titan Pharmaceuticals: 3Q Earnings Snapshot

SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Wednesday reported a loss of $2 million in its third quarter.

TTNP : 0.27 (unch)
Titan Pharmaceuticals Reports Third Quarter 2018 Financial Results

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing and commercializing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous...

TTNP : 0.27 (unch)
Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2018 Financial Results

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 0.27 (unch)
Biotech Stocks and the Midterm Elections

HENDERSON, NV / ACCESSWIRE / November 7, 2018 / Midterm elections are expected to result in a split Congress, which should increase predictability for the biotech industry, and prevent, what some see as...

PPCHD : 1.2000 (+20.00%)
TTNP : 0.27 (unch)
AYTU : 0.90 (-2.17%)
PBYI : 22.58 (-2.71%)
3 Stocks To Watch As Healthcare Market Evolves

CORAL GABLES, FL / ACCESSWIRE / November 5, 2018 / Healthcare companies are taking a new and novel approach the in the form of new innovation that takes the guesswork out of tracking health & reporting...

RAD : 0.89 (-1.54%)
TTNP : 0.27 (unch)
Surge In Healthcare Growth Sees Rally In These 3 Stocks On Friday

CORAL GABLES, FL / ACCESSWIRE / November 2, 2018 / Over the last few days, prices of the iShares Nasdaq Biotech ETF (IBB) as well as the SPDR Healthcare ETF (XLV) have recovered from previous lows this...

TTNP : 0.27 (unch)
PACB : 7.47 (-0.53%)
3 Healthcare Stocks that Could Move on Industry Growth

CORAL GABLES, FL / ACCESSWIRE / October 30, 2018 / According to the MarketsAndMarkets* report "by Product (EHR, RIS, PACS, VNA, CPOE, HIE, Telehealth, Healthcare Analytics, Population Health Management,...

TTNP : 0.27 (unch)
ACHV : 1.45 (+0.69%)
Thinking about buying stock in Aurora Cannabis Inc, Boeing, Helios and Matheson Analytics Inc, Planet Green Holdings or Titan Pharmaceuticals?

InvestorsObserver issues critical PriceWatch Alerts for ACB, BA, HMNY, PLAG, and TTNP.

HMNY : 0.02 (unch)
ACBFF : 8.6900 (-12.80%)
TTNP : 0.27 (unch)
BA : 318.75 (-2.06%)
These 3 Stocks Are Moving Higher This Month

CORAL GABLES, FL / ACCESSWIRE / October 23, 2018 / Markets were mostly red toward the opening bell on Tuesday. Many equities fell victim to the global issues troubling the . Mainly things like mining stocks...

TTNP : 0.27 (unch)
AMRX : 16.11 (-1.35%)
Titan Pharmaceuticals Moving Forward with its ProNeuraâ?¢ Technology, Analysts Review

NEW YORK, NY / ACCESSWIRE / October 15, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

TTNP : 0.27 (unch)
Titan Strengthens Executive Leadership Team With Appointment Of Chief Commercial Officer

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a commercial stage company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous...

TTNP : 0.27 (unch)
Titan Pharmaceuticals Prices $9,500,000 Public Offering

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company"), a commercial stage company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM)...

TTNP : 0.27 (unch)
Titan Awarded NIDA Grant For The Development Of A Nalmefene Implant For The Prevention Of Opioid Addiction Relapse

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced that it has been awarded a two year grant of approximately $6.7 million from the National Institutes of Health's National Institute on Drug Abuse...

TTNP : 0.27 (unch)
Titan Pharmaceuticals: 1Q Earnings Snapshot

SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Tuesday reported a loss of $2.6 million in its first quarter.

TTNP : 0.27 (unch)
Titan Pharmaceuticals Reports First Quarter 2018 Financial Results

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 0.27 (unch)
Titan Pharmaceuticals To Report First Quarter 2018 Financial Results On May 15, 2018

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 0.27 (unch)
Titan Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 2, 2018 / Titan Pharmaceuticals, Inc. (NASDAQ: ) will be discussing their earnings results in their Q4 Earnings Call to be held on April 2, 2018 at 4:15 PM Eastern Time....

TTNP : 0.27 (unch)
Titan Pharmaceuticals reports 4Q loss

SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Monday reported a loss of $3.7 million in its fourth quarter.

TTNP : 0.27 (unch)

Van Meerten Stock Picks

Tesla According to Peter Lynch
Today's Barchart Chart of the Day will be the auto maker Tesla (TSLA).
TSLA -11.08
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

cmdty Insider - Ag Market Commentary

Today's Commentary

Corn futures ended the Friday session with most contracts steady to 1/2 cent higher, as Dec expired at $3.76 3/4. USDA reported a private export sale of 125,000 MT of corn to Japan this morning. Corn export commitments through December 6 were 16.3% l...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar